GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » SCWorx Corp (NAS:WORX) » Definitions » Cash Conversion Cycle

WORX (SCWorx) Cash Conversion Cycle : -188.94 (As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is SCWorx Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

SCWorx's Days Sales Outstanding for the three months ended in Dec. 2024 was 62.09.
SCWorx's Days Inventory for the three months ended in Dec. 2024 was 0.
SCWorx's Days Payable for the three months ended in Dec. 2024 was 251.03.
Therefore, SCWorx's Cash Conversion Cycle (CCC) for the three months ended in Dec. 2024 was -188.94.


SCWorx Cash Conversion Cycle Historical Data

The historical data trend for SCWorx's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SCWorx Cash Conversion Cycle Chart

SCWorx Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Conversion Cycle
Get a 7-Day Free Trial Premium Member Only Premium Member Only -29.05 -74.43 -136.49 -192.49 -200.65

SCWorx Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -254.17 -237.14 -292.82 -189.40 -188.94

Competitive Comparison of SCWorx's Cash Conversion Cycle

For the Health Information Services subindustry, SCWorx's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SCWorx's Cash Conversion Cycle Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, SCWorx's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where SCWorx's Cash Conversion Cycle falls into.


;
;

SCWorx Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

SCWorx's Cash Conversion Cycle for the fiscal year that ended in Dec. 2024 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=41.38+0-242.03
=-200.65

SCWorx's Cash Conversion Cycle for the quarter that ended in Dec. 2024 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=62.09+0-251.03
=-188.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SCWorx  (NAS:WORX) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


SCWorx Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of SCWorx's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


SCWorx Business Description

Traded in Other Exchanges
N/A
Address
100 South Ashley Drive, Suite 100, Tampa, FL, USA, 33602
SCWorx Corp is a provider of data content and services related to the repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. Its software enables a healthcare provider to simplify and organize its data, allows the data to be utilized across multiple internal software applications, and provides the basis for sophisticated data analytics. The company has developed and markets healthcare information technology solutions and associated services to improve healthcare processes and information flow within hospitals and other healthcare facilities.
Executives
Vincent Michael Matozzo director 412 RICHARD LANE, ORANGE CT 06477
Christopher John Kohler officer: Chief Financial Officer 1149 CANTERBERRY LN, PARKER CO 80138
Steven Wallitt director C/O SCWORX CORP., 590 MADISON AVENUE, 21ST FLOOR, NEW YORK NY 10022
John C Ferrara director C/O EDGAR ONLINE, INC., 50 WASHINGTON STREET, NORWALK CT 06854
Steven Ross Horowitz director 4 MELISSA COURT, MONTVILLE NJ 07045
Marc Sanford Schessel director, 10 percent owner, officer: CEO 4 JACOBS LANE, NEW PALTZ NY 12561
Irby Alton F Iii director C/O MCKESSON CORP, ONE POST ST., SAN FRANCISCO CA 94104
Miller Charles Kenneth Iii director 100 METROPLEX, EDISON NJ 08817
Timothy Andrew Hannibal officer: President, COO 590 MADISON AVE, NEW YORK NY 10022
Mark Shefts director 160 SUMMIT AVE, MONTVALE NJ 07645
John C Price other: Former CFO 4721 IRONTON STREET, BUILDING A, DENVER CO 80239
Robert Steven Christie director 34 SAN MARCO STREET, WEST WINDSOR NJ 08550
Ira E. Ritter director C/O RITTER PHARMACEUTICALS INC., 1801 CENTURY PARK EAST, SUITE 1820, LOS ANGELES CA 90096
Knuettel Ii Francis director 205 NEWBURY ST, SUITE 204, FRAMINGHAM MA 01701
James Thaddeus Schweikert officer: Chief Operating Officer 7783 SOARING EAGLE CT., CINCINNATI OH 45244